BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join
back to Directory

Insitro

Insitro logo

Website
http://www.insitro.com/
Founded
2018
Patents
11
Publications
49

Technologies

AI Companies (Drug Discovery) Aging Research

A constellation of technologies now allows us to construct, perturb, and observe biological model systems in the laboratory, allowing the generation of biomolecular data at unprecedented breadth and scale. At the same time, the tools of data science and machine learning are now solving problems previously thought to be decades away from solution.
We aim to combine these technologies to develop a new approach to drug development that might help us cure more people, sooner, and at a much lower cost.

drug development life sciences Machine Learning


Posts Mentioning This Company

Pharmaceutical AI in 2021: Key Developments So Far

Aug. 9, 2021  
Table of Contents:   Introduction Artificial intelligence (AI) in drug discovery yields breakthroughs The abundance of venture capital, major funding rounds IPOs of AI Pharma Companies in 2021 New AI-driven biotech startups founded in 2020 Notable AI-focused collaborations involving “big pharma” players AI adoption by the contract research organizations (CROs)  …

Major VC Rounds For AI-driven Biotechs in 2020

July 8, 2020  
The ongoing COVID19 crisis forced biotech-oriented venture capitalists (VC) to somewhat slow down the pace of their usual deal-flow -- according to data by PitchBook biopharma venture deals in 2020 are down roughly 16% compared to last year.  However, there is still a lot going on in drug discovery and …
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

 

R&D Platform

Armed with an understanding of disease architecture, we combine patient-derived, induced pluripotent stem cells (iPSCs), genome editing, high content cellular phenotyping, and machine learning to build in vitro models of disease. We design these disease models to be maximally predictive of human clinical outcomes by optimizing for genetics, cell-type, environment, and multidimensional data collection.

News

  • 2024-04-03
    New Landmark Report Unveils a Decade of AI Transformation in Drug Discovery
  • 2022-06-06
    Insilico Medicine Snaps Up $60M to Create Robotic Lab of the Future

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.